Literature DB >> 18950645

Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.

Fumio Tanaka1, Kazunari Tominaga, Masahiro Ochi, Tetsuya Tanigawa, Toshio Watanabe, Yasuhiro Fujiwara, Kensuke Ohta, Nobuhide Oshitani, Kazuhide Higuchi, Tetsuo Arakawa.   

Abstract

AIMS: Mesenchymal stem cells (MSCs) may modulate inflammatory responses resulting in improvement in inflammatory diseases, as well as tissue regeneration via cellular differentiation. We examined the therapeutic effects of exogenously administered MSCs in dextran sulfate sodium (DSS)-induced colitis in rats. MAIN
METHODS: Experimental colitis was produced in inbred male Lewis rats by administration of 4% DSS in drinking water for 7 days. MSCs (5x10(6) cells) which were isolated from whole marrow cells and cultured in an optimal medium for MSC outgrowth were administered to the treated rats via the tail vein on days 0, 2, and 4. On day 7, we evaluated colon length, histological changes, and colonic various mRNA expressions by RT-PCR. Localization of MSCs was evaluated using a green-fluorescent cell linker dye. To evaluate the anti-inflammatory action of MSCs, we assayed LPS-induced TNF-alpha secretion in a co-culture of MSCs and monocytes (THP-1 cells) using ELISA. KEY
FINDINGS: MSCs reduced in bloody stools, weight loss, colon shortening, and microscopic injuries. In the rectum of MSCs-treated rats, mRNA expression of TNF-alpha, IL-1beta, and COX-2 decreased to 40, 15, and 15% of their respective control levels. MSCs significantly suppressed mRNA expression of VEGF, HGF, and b-FGF to 40, 25, and 25% of their respective control levels. Green-fluorescent-labeled MSCs were found only within the lamina propria in inflamed regions. LPS-induced TNF-alpha secretion by THP-1 cells was significantly suppressed by co-culture with MSCs dose-dependently. SIGNIFICANCE: We conclude that exogenous MSCs accumulated in inflamed tissues and ameliorated DSS-induced colitis via a local anti-inflammatory action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950645     DOI: 10.1016/j.lfs.2008.09.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  49 in total

1.  Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis.

Authors:  Yueqiu Chen; Yuxian Song; Huishuang Miao; Yujun Xu; Mingming Lv; Tingting Wang; Yayi Hou
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

2.  Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.

Authors:  Tao Sun; Guang-Zhou Gao; Rong-Fu Li; Xin Li; Da-Wei Li; Shan-Shan Wu; Anthony Et Yeo; Bo Jin
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue.

Authors:  Xingxing Liu; Dongmei Zuo; Heng Fan; Qing Tang; Zhexing Shou; Dan Cao; Zhou Zou
Journal:  J Mol Histol       Date:  2013-10-12       Impact factor: 2.611

4.  Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Authors:  Fabiany da Costa Gonçalves; Natália Schneider; Fernanda Otesbelgue Pinto; Fabíola Schons Meyer; Fernanda Visioli; Bianca Pfaffenseller; Patrícia Luciana da Costa Lopez; Eduardo Pandolfi Passos; Elizabeth Obino Cirne-Lima; Luíse Meurer; Ana Helena Paz
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies.

Authors:  Yoshiaki Hayashi; Kenta Narumi; Shigetsugu Tsuji; Toshinari Tsubokawa; Masa-aki Nakaya; Tomohiko Wakayama; Masahiko Zuka; Tohru Ohshima; Masakazu Yamagishi; Toshihide Okada
Journal:  Int J Colorectal Dis       Date:  2011-06-15       Impact factor: 2.571

6.  Characterization of a multilayer heparin coating for biomolecule presentation to human mesenchymal stem cell spheroids.

Authors:  J Lei; L T McLane; J E Curtis; J S Temenoff
Journal:  Biomater Sci       Date:  2014-05-01       Impact factor: 6.843

7.  Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?

Authors:  Ferenc Sipos; Györgyi Muzes
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 8.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

9.  Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Authors:  Amir Kol; Soraya Foutouhi; Naomi J Walker; Nguyet T Kong; Bart C Weimer; Dori L Borjesson
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

10.  Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis.

Authors:  R Marcon; R F Claudino; R C Dutra; A F Bento; E C Schmidt; Z L Bouzon; R Sordi; R L T Morais; J B Pesquero; J B Calixto
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.